{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:47:11Z","timestamp":1792039631469,"version":"4.4.0"},"reference-count":19,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["23FC1024"],"award-info":[{"award-number":["23FC1024"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K07852"],"award-info":[{"award-number":["23K07852"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["American J Hematol"],"DOI":"10.1002\/ajh.70523","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:13:59Z","timestamp":1792037639000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Combination Therapy of Vinblastine, Prednisolone, Methotrexate, and 6\u2010Mercaptopurine as a Front\u2010Line Therapy for Adult Patients With Langerhans Cell Histiocytosis"],"prefix":"10.1002","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1714-1347","authenticated-orcid":false,"given":"Aki","family":"Sato","sequence":"first","affiliation":[{"name":"Department of Hematology and Oncology, The Institute of Medical Science Research Hospital The University of Tokyo  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Yusa","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The Institute of Medical Science Research Hospital The University of Tokyo  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihisa","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The Institute of Medical Science Research Hospital The University of Tokyo  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Division of Hematopoietic Disease Control, The Institute of Medical Science The University of Tokyo  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eigo","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Division of Health Medical Intelligence, Human Genome Center, The Institute of Medical Science The University of Tokyo  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2031-7385","authenticated-orcid":false,"given":"Koji","family":"Jimbo","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, The Institute of Medical Science Research Hospital The University of Tokyo  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, The Institute of Medical Science Research Hospital The University of Tokyo  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8788-2522","authenticated-orcid":false,"given":"Masanori","family":"Nojima","sequence":"additional","affiliation":[{"name":"Division of Advanced Medicine Promotion, The Institute of Medical Science The University of Tokyo  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2989-308X","authenticated-orcid":false,"given":"Seiya","family":"Imoto","sequence":"additional","affiliation":[{"name":"Division of Health Medical Intelligence, Human Genome Center, The Institute of Medical Science The University of Tokyo  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9016-1948","authenticated-orcid":false,"given":"Arinobu","family":"Tojo","sequence":"additional","affiliation":[{"name":"Institute of Innovation Advancement Institute of Science Tokyo  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6526-0992","authenticated-orcid":false,"given":"Yasuhito","family":"Nannya","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, The Institute of Medical Science Research Hospital The University of Tokyo  Tokyo Japan"},{"name":"Division of Hematopoietic Disease Control, The Institute of Medical Science The University of Tokyo  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"issue":"5","key":"e_1_2_1_8_2_1","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.hoc.2015.06.003","article-title":"Cell(s) of Origin of Langerhans Cell Histiocytosis","volume":"29","author":"Collin M.","year":"2015","journal-title":"Hematology\/Oncology Clinics of North America"},{"issue":"11","key":"e_1_2_1_8_3_1","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","article-title":"Recurrent BRAF Mutations in Langerhans Cell Histiocytosis","volume":"116","author":"Badalian\u2010Very G.","year":"2010","journal-title":"Blood"},{"issue":"2","key":"e_1_2_1_8_4_1","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1182\/blood.2024026671","article-title":"BRAF V600E\u2010Positive Mononuclear Cells in Blood at Diagnosis Portend Treatment Failure and Neurodegeneration in Pediatric LCH","volume":"146","author":"Lin H.","year":"2025","journal-title":"Blood"},{"issue":"7","key":"e_1_2_1_8_5_1","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1158\/1535-7163.MCT-20-1075","article-title":"Mutation in Cell\u2010Free DNA, Rather Than in Lesion Tissues, at Diagnosis Is an Independent Prognostic Factor in Children With Langerhans Cell Histiocytosis","volume":"20","author":"Wang C. J.","year":"2021","journal-title":"Molecular Cancer Therapeutics"},{"issue":"9","key":"e_1_2_1_8_6_1","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1111\/cas.15879","article-title":"Clinical and Prognostic Features of Langerhans Cell Histiocytosis in Adults","volume":"114","author":"Sato A.","year":"2023","journal-title":"Cancer Science"},{"issue":"1","key":"e_1_2_1_8_7_1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12185-012-1245-0","article-title":"Therapeutic Outcome of Multifocal Langerhans Cell Histiocytosis in Adults Treated With the Special C Regimen Formulated by the Japan LCH Study Group","volume":"97","author":"Morimoto A.","year":"2013","journal-title":"International Journal of Hematology"},{"issue":"5","key":"e_1_2_1_8_8_1","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/bjh.16449","article-title":"Long\u2010Term Efficacy and Safety of 2CdA (Cladribine) in Extra\u2010Pulmonary Adult\u2010Onset Langerhans Cell Histiocytosis: Analysis of 23 Cases From the French Histiocytosis Group and Systematic Literature Review","volume":"189","author":"N\u00e9el A.","year":"2020","journal-title":"British Journal of Haematology"},{"issue":"5","key":"e_1_2_1_8_9_1","doi-asserted-by":"crossref","first-page":"E146","DOI":"10.1002\/ajh.26119","article-title":"Single\u2010Agent Cladribine as an Effective Front\u2010Line Therapy for Adults With Langerhans Cell Histiocytosis","volume":"96","author":"Goyal G.","year":"2021","journal-title":"American Journal of Hematology"},{"issue":"9","key":"e_1_2_1_8_10_1","first-page":"E235","article-title":"Methotrexate and Cytarabine for Adult Patients With Newly Diagnosed Langerhans Cell Histiocytosis: A Single Arm, Single Center, Prospective Phase 2 Study","volume":"95","author":"Cao X. X.","year":"2020","journal-title":"American Journal of Hematology"},{"issue":"4","key":"e_1_2_1_8_11_1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s41375-024-02174-1","article-title":"Phase 2 Study Using Low Dose Cytarabine for Adult Patients With Newly Diagnosed Langerhans Cell Histiocytosis","volume":"38","author":"Chang L.","year":"2024","journal-title":"Leukemia"},{"issue":"1","key":"e_1_2_1_8_12_1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12185-016-1993-3","article-title":"Intensified and Prolonged Therapy Comprising Cytarabine, Vincristine and Prednisolone Improves Outcome in Patients With Multisystem Langerhans Cell Histiocytosis: Results of the Japan Langerhans Cell Histiocytosis Study Group\u201002 Protocol Study","volume":"104","author":"Morimoto A.","year":"2016","journal-title":"International Journal of Hematology"},{"issue":"3","key":"e_1_2_1_8_13_1","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the Freely Available Easy\u2010To\u2010Use Software \u2018EZR\u2019 for Medical Statistics","volume":"48","author":"Kanda Y.","year":"2013","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_1_8_14_1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.leukres.2017.09.012","article-title":"Emerging Role of NUDT15 Polymorphisms in 6\u2010Mercaptopurine Metabolism and Dose Related Toxicity in Acute Lymphoblastic Leukaemia","volume":"62","author":"Singh M.","year":"2017","journal-title":"Leukemia Research"},{"issue":"2","key":"e_1_2_1_8_15_1","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/bjh.19830","article-title":"Long\u2010Term Follow\u2010Up of Methotrexate and Cytarabine in Adult Patients With Langerhans Cell Histiocytosis","volume":"206","author":"Lin H.","year":"2025","journal-title":"British Journal of Haematology"},{"issue":"1","key":"e_1_2_1_8_16_1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13023-017-0651-z","article-title":"Vinblastine Chemotherapy in Adult Patients With Langerhans Cell Histiocytosis: A Multicenter Retrospective Study","volume":"12","author":"Tazi A.","year":"2017","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"8","key":"e_1_2_1_8_17_1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043257","article-title":"Optimal Therapy for Adults With Langerhans Cell Histiocytosis Bone Lesions","volume":"7","author":"Cantu M. A.","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"e_1_2_1_8_18_1","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/annonc\/mdp455","article-title":"MACOP\u2010B Regimen in the Treatment of Adult Langerhans Cell Histiocytosis: Experience on Seven Patients","volume":"21","author":"Derenzini E.","year":"2010","journal-title":"Annals of Oncology"},{"issue":"1","key":"e_1_2_1_8_19_1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/08880018.2022.2072986","article-title":"Efficacy and Safety of Vemurafenib in Langerhans Cell Histiocytosis (LCH): A Systematic Review and Meta\u2010Analysis","volume":"40","author":"Mohapatra D.","year":"2023","journal-title":"Pediatric Hematology and Oncology"},{"issue":"12","key":"e_1_2_1_8_20_1","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1182\/blood.V93.12.4125","article-title":"Cladribine Activity in Adult Langerhans\u2010Cell Histiocytosis","volume":"93","author":"Saven A.","year":"1999","journal-title":"Blood"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.70523","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ajh.70523","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.70523","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:14:02Z","timestamp":1792037642000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.70523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":19,"alternative-id":["10.1002\/ajh.70523"],"URL":"https:\/\/doi.org\/10.1002\/ajh.70523","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"assertion":[{"value":"2026-05-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"ajh.70523"}}